Envestnet Asset Management’s Neuronetics STIM Stock Holding History

Envestnet Asset Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-127,680	Closed	-$877K	–	4101
2022 Q4	$877K	Buy	127,680 +3,648	+3%	+$17.2K	﹤0.01%	2746
2022 Q3	$394K	Buy	124,032 +17,628	+17%	+$64.1K	﹤0.01%	3175
2022 Q2	$342K	Buy	106,404 +25,593	+32%	+$74.3K	﹤0.01%	3285
2022 Q1	$245K	Buy	80,811 +45,928	+132%	+$155K	﹤0.01%	3563
2021 Q4	$156K	Buy	34,883 +13,465	+63%	+$65.9K	﹤0.01%	3704
2021 Q3	$141K	Buy	21,418 +3,070	+17%	+$29.4K	﹤0.01%	3553
2021 Q2	$294K	Buy	18,348 +7,496	+69%	+$104K	﹤0.01%	3303
2021 Q1	$134K	Buy	+10,852	New	+$166K	﹤0.01%	3399

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Envestnet Asset Management's STIM Position: Q1 2023 in Review

Envestnet Asset Management sold out of Neuronetics (STIM) in Q1 2023, closing a stake of 127,680 shares — an estimated $877K sold.

Envestnet Asset Management first reported a position in STIM in Q1 2021 and held it in 8 quarters. The position peaked at $877K in Q4 2022. 74 funds tracked by Wall St. Rank hold STIM as of Q1 2023.

Envestnet Asset Management reported no remaining Neuronetics position as of Q1 2023 after selling out during the quarter.
Envestnet Asset Management sold 127,680 Neuronetics shares in Q1 2023, an estimated $877K.
Envestnet Asset Management first reported a position in Neuronetics in Q1 2021 and held it in 8 quarters.
Envestnet Asset Management's Neuronetics position peaked at $877K in Q4 2022.
74 funds tracked by Wall St. Rank held Neuronetics as of Q1 2023.

Based on Envestnet Asset Management's 13F filing for Q1 2023, filed 11 May 2023.